Abstract
Melanotic schwannoma (MS) is a very rare nerve sheath tumor characterized by melanin-producing cells that display ultrastructural features of Schwann cells [24]. This type of tumor was first described in 1932 [17] and occurs primarily in the paraspinal region, originating from the spinal nerve roots or sympathetic ganglia. Craniofacial or intracranial locations are rare [15] [21]. However, extraneural locations such as skin, soft tissues, bone and viscera have also been described [5] [7]. In a minority of cases, MS may have multiple nodules [6] [26]. Although MS have been considered to be slow-growing, benign tumors, prognosis can be poor as a result of local recurrence or malignant progression [9]. Melanotic schwannoma occurs in relatively young adults (mean age 35 years) and have no sex predilection. Epidemically, two types of tumors can be distinguished: the sporadic variant and psammomatous melanotic schwannoma associated with the Carney complex, a rare, autosomal dominant hereditary syndrome characterized by variegated skin pigmentation, cardiac myxomas, endocrine overactivity, and nerve sheath tumors [2]. Psammoma bodies are present in more than 50% of MS. Immunohistochemistry reveals that S100, HMB-45 and vimentin are strongly expressed by most cells in MS [15] [18].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Central European Neurosurgery - Zentralblatt für Neurochirurgie
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.